Alkermes shares fall after FDA blocks antidepressant approval - MarketWatch

Alkermes shares fall after FDA blocks antidepressant approval  MarketWatchAlkermes PLC ALKS, +0.64% said late Friday that the Food and Drug Administration told the biotech drug maker that it is unable to approve one of its ...